Washington, DC—July 1, 2003—Thomas E. Shenk, Ph.D., Elkins Professor and Chair of the Department of Molecular Biology, Princeton University, has assumed the presidency of the American Society for Microbiology (ASM). He was elected in 2001 and has served as president-elect for the past year.
Shenk received his Ph.D. in microbiology from Rutgers University and was a postdoctoral fellow in biochemistry at Stanford University. He received a B.S. summa cum laude from the University of Detroit. He has held previous appointments at the University of Connecticut School of Medicine and the State University of New York at Stony Brook School of Medicine.
Shenk is a virologist who has developed methods for the genetic and biochemical dissection of human adenovirus and human cytomegalovirus. His work has elucidated the functions of numerous viral gene products, and he has identified cellular genes that play roles during viral replication and pathogenesis.
His honors include membership in the National Academy of Sciences and the Institute of Medicine. He is a Fellow of the American Academy of Arts and Sciences and the American Academy of Microbiology. He has been a Howard Hughes Medical Institute Investigator and is an American Cancer Society Professor. He received the Eli Lilly Award in Microbiology from the ASM in 1982.
Shenk is a member of the Boards of Directors of Merck and Company and Cell Genesys. He is a member of the President’s Advisory Group of Fox Chase Cancer Center and has chaired the Sloan General Motors Prize Selection Committee. He was editor of the Journal of Virology 1984-1994 and is a past president of the American Society for Virology.
The American Society for Microbiology is the largest single life science society, composed of over 42,000 scientists and health professionals. Its mission is to promote research and research training in the microbiological sciences and to assist communication between scientists, policy makers, and the public to improve health, the environment, and economic well-being.